Company: SNSE
Filing Date: 2025-07-09
Form Type: 8-K
Source: 0001193125-25-157113
Chunk: 0

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-07-09
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01      Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.  

On July 2, 2025, Sensei Biotherapeutics, Inc. (the “ Company”) received a letter from the Listing Qualifications Staff (the “ Staff”) of The Nasdaq Stock Market LLC (“ Nasdaq”) notifying the Company that the Staff has determined that for 10 consecutive business days, from June 17, 2025 to July 1, 2025, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. Accordingly, the Staff has determined that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                          Sensei Biotherapeutics, Inc.   
  Date: July 9, 2025      /s/ Christopher W. Gerry       
                          Christopher W. Gerry           
                          General Counsel and Secretary